Patients are not just the recipients, but the reason behind our science. We look beyond symptoms to the entire patient experience, developing tailored solutions that aim to minimize the effects of disease.
- Understanding how patients will respond to treatment, the genomics behind each disease and the optimal delivery methods are the building blocks of our strategy. By focusing on the foundational elements of treatment, we can more effectively target and treat the underlying cause of a condition.
- We set a high bar for success in our clinical trials—always aspiring to achieve remission, not merely symptom management.
See more immunology resources for our patients here.
Read a Q&A with Lisa Olson, VP, Immunology R&D